802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study.

Saved in:
Bibliographic Details
Title: 802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study.
Authors: Brunelli, M.1 (AUTHOR), Buti, S.2 (AUTHOR), Rebuzzi, S.E.3 (AUTHOR), Milella, M.4 (AUTHOR), Vellone, V.5 (AUTHOR), Bersanelli, M.2 (AUTHOR), Maruzzo, M.6 (AUTHOR), Basso, U.6 (AUTHOR), Signori, A.7 (AUTHOR), Martelli, V.3 (AUTHOR), Catalano, F.3 (AUTHOR), Damassi, A.8 (AUTHOR), Murianni, V.3 (AUTHOR), Merler, S.4 (AUTHOR), Casartelli, C.2 (AUTHOR), Fornarini, G.9 (AUTHOR)
Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS607-S608. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152696599
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Brunelli%2C+M%2E%22">Brunelli, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Buti%2C+S%2E%22">Buti, S.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rebuzzi%2C+S%2EE%2E%22">Rebuzzi, S.E.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Milella%2C+M%2E%22">Milella, M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vellone%2C+V%2E%22">Vellone, V.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bersanelli%2C+M%2E%22">Bersanelli, M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maruzzo%2C+M%2E%22">Maruzzo, M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Basso%2C+U%2E%22">Basso, U.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Signori%2C+A%2E%22">Signori, A.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martelli%2C+V%2E%22">Martelli, V.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Catalano%2C+F%2E%22">Catalano, F.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Damassi%2C+A%2E%22">Damassi, A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Murianni%2C+V%2E%22">Murianni, V.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Merler%2C+S%2E%22">Merler, S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Casartelli%2C+C%2E%22">Casartelli, C.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fornarini%2C+G%2E%22">Fornarini, G.</searchLink><relatesTo>9</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 4, Vol. 31, pS607-S608. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152696599
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2020.08.2073
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S607
    Titles:
      – TitleFull: 802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Brunelli, M.
      – PersonEntity:
          Name:
            NameFull: Buti, S.
      – PersonEntity:
          Name:
            NameFull: Rebuzzi, S.E.
      – PersonEntity:
          Name:
            NameFull: Milella, M.
      – PersonEntity:
          Name:
            NameFull: Vellone, V.
      – PersonEntity:
          Name:
            NameFull: Bersanelli, M.
      – PersonEntity:
          Name:
            NameFull: Maruzzo, M.
      – PersonEntity:
          Name:
            NameFull: Basso, U.
      – PersonEntity:
          Name:
            NameFull: Signori, A.
      – PersonEntity:
          Name:
            NameFull: Martelli, V.
      – PersonEntity:
          Name:
            NameFull: Catalano, F.
      – PersonEntity:
          Name:
            NameFull: Damassi, A.
      – PersonEntity:
          Name:
            NameFull: Murianni, V.
      – PersonEntity:
          Name:
            NameFull: Merler, S.
      – PersonEntity:
          Name:
            NameFull: Casartelli, C.
      – PersonEntity:
          Name:
            NameFull: Fornarini, G.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2020 Supplement 4
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 31
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1